30 October 2024
ANANDA
DEVELOPMENTS PLC
("Ananda"
or the "Company")
Investor
Presentation via Investor Meet Company.
Ananda Developments plc (AQSE: ANA),
a Company focused on the development of CBD based therapies for the
treatment of a range of complex inflammatory pain conditions, is
pleased to announce that following the release of the Company's
Interims Results, Melissa Sturgess will provide a live update
presentation via Investor Meet Company on 15 Nov 2024, 12:30
GMT.
The presentation is open to all
existing and potential shareholders. Questions can be submitted
pre-event via your Investor Meet Company dashboard up until 14 Nov
2024, 09:00 GMT, or at any time during the live
presentation.
Investors can sign up to Investor
Meet Company for free and add to meet Ananda Developments Plc
via:
https://www.investormeetcompany.com/ananda-developments-plc/register-investor
Investors who already follow Ananda
Developments Plc on the Investor Meet Company platform will
automatically be invited.
-Ends-
To stay abreast of the latest
developments at Ananda, we encourage you to follow our social media
channels which are:
·
Investor Hub: investors.anandadevelopments.com
·
Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=
·
LinkedIn: https://www.linkedin.com/company/anadevelopments/
·
Twitter:
https://twitter.com/AnandaPlc
·
Investor Meet Company:
https://www.investormeetcompany.com/ananda-developments-plc/register-investor
-Ends-
The Directors of the Company accept
responsibility for the contents of this
announcement.
ANANDA DEVELOPMENTS
PLC
|
+44
(0)7463 686 497
|
|
ir@anandadevelopments.com
|
Chief Executive Officer
|
|
Melissa Sturgess
|
|
|
|
Finance
Director
|
|
Jeremy
Sturgess-Smith
|
|
|
|
SP ANGEL CORPORATE FINANCE
LLP
|
+44 (0)20
3470 0470
|
|
|
Corporate Finance
|
|
Richard Morrison
|
|
|
|
|
|
Corporate
Broking
|
|
Abigail Wayne
|
|
Rob Rees
|
|
Yellow Jersey PR (media
enquiries)
Sarah
MacLeod
Charles
Goodwin
Zara
McKinlay
|
+44 (0)20
3004 9512
ananda@yellowjerseypr.com
|
About Ananda Developments
Ananda is an AQSE-listed
life sciences company focused on the research and
clinical development of CBD-based therapies for a range of complex
inflammatory pain conditions.
For more information, please
visit: https://anandadevelopments.com
https://investors.anandadevelopments.com/link/drLkqe